Medical Research News

RSS

New study shows how exercise hormone reduces multiple sclerosis symptoms

A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis (MS).

21 May 2026

HonorHealth Research Institute tests steam therapy for diabetes treatment

HonorHealth Research Institute is looking to become the first research facility in the nation to begin a new clinical trial that aims to modify the lining of the digestive tract with the use of steam energy to control type II diabetes without the use of drugs.

21 May 2026

Scientists discover how vitamin K pathway regulates bone remodeling

Bone is continuously renewed through a process known as bone remodeling, in which osteoblasts (bone-forming cells) build new bone, while osteoclasts (bone-resorbing cells) remove older mineralized tissue.

21 May 2026

Structured approach to a healthy lifestyle may help slow important aspects of aging

Researchers at Wake Forest University School of Medicine found evidence of slowed aging from lifestyle behaviors like healthy eating and exercise as part of a major clinical trial.

21 May 2026

Uneven grey matter loss serves as a powerful new biomarker for early neurodegeneration

Universitat Oberta de Catalunya Alzheimer's disease begins to weave a web in the brain and remodel neuronal tissue 15 to 20 years before the first symptoms appear. From the time this happens, however, until the disease is diagnosed and, later, enters an advanced phase, it progresses along a continuum of changes to the brain.

21 May 2026

Elevated blood glucose during pregnancy signals a significantly higher future diabetic risk

Gestational diabetes is a strong risk factor for future type 2 diabetes, even in women with normal pre-pregnancy weight, according to a study at the University of Gothenburg. The researchers call for earlier testing and better follow-up.

21 May 2026

Muscle-specific molecular signal regulates how human heart cells produce and utilize critical energy

Researchers have identified a key protein that may help failing hearts regain function, offering new insight into why some hearts recover while others do not.

21 May 2026

First-of-its-kind pregnancy hormone test reveals why female IBD patients face severe symptom flares

Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn's disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated.

21 May 2026

Key neural circuit helps the brain “change gears”

Most people have experienced the feeling: switching from one task to another, only to find the brain momentarily stuck in the old mode of thinking. Sometimes, even after realizing a strategy no longer works, the mind keeps returning to it anyway.

21 May 2026

New gene expression signature may guide immunotherapy for resistant prostate cancer patients

Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are more likely to experience lasting benefits from combined immunotherapy treatment.

21 May 2026

New CA19-9 threshold improves pancreatic cancer risk prediction accuracy

A dual-threshold model for measuring the pancreatic tumor marker serum carbohydrate antigen 19-9 (CA19-9) identified patients with pancreatic cancer who had high-risk disease despite having low CA19-9 levels because of a genetic variation that impairs their ability to produce this biomarker.

21 May 2026

Rural siblings of neurodivergent children face poorer mental wellbeing

New Curtin University-led research has found siblings of people with neurodevelopmental conditions in regional and remote Australia are struggling with poorer wellbeing and are more likely to feel overlooked.

21 May 2026

Study supports reusable catheters as safe and cost-effective alternatives

Reusable catheters are just as safe for patients as single-use ones and do not increase the risk of urinary tract infections, a new study has found.

21 May 2026

Common food preservatives linked to higher cardiovascular disease risks

Eating foods that contain common preservative food additives may increase the risks of high blood pressure and cardiovascular disease, according to research published in the European Heart Journal today.

21 May 2026

New vaccine approach targets broad protection against arenavirus infections

Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine.

21 May 2026

Small T-cell subset drives powerful multiple myeloma immunotherapy responses

Researchers from The University of Osaka find that only a small fraction of T cells may drive the robust anti-cancer response seen in breakthrough multiple myeloma immunotherapy.

21 May 2026

Mid-career surgeons show highest likelihood of leaving clinical practice

Surgeons are an integral part of the health care system, supplying critical and urgent care in nearly every field of medicine.

21 May 2026

Universal free school meals linked to fewer student suspensions

A study published in Economic Inquiry provides new evidence that universal free school meals can meaningfully reduce out‐of‐school suspensions in both elementary and secondary schools.

21 May 2026

Study defines realistic performance goals for pediatric emergency departments

A large, multi-center study led by Ann & Robert H. Lurie Children's Hospital of Chicago derived "achievable benchmarks of care" (ABCs) using electronic health record data, which allows pediatric emergency departments across the country to set high yet realistic performance goals.

21 May 2026

Oral AD109 improves sleep apnea severity but tolerability remains a challenge

AD109, an investigational once-daily oral combination of aroxybutynin and atomoxetine, significantly improved airway obstruction and oxygenation in adults with mild-to-severe obstructive sleep apnea who could not use PAP therapy. However, symptom improvements did not clearly differ from placebo, and about one in five AD109 recipients discontinued treatment due to adverse events.

21 May 2026